| Dr David Christian Larrymore, MD | |
|
565 Eureka Way, Sequim, WA 98382-5074 | |
| (360) 582-0808 | |
| (360) 683-2712 |
| Full Name | Dr David Christian Larrymore |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 16 Years |
| Location | 565 Eureka Way, Sequim, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427218270 | NPI | - | NPPES |
| 2189218 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 25621 (Nebraska) | Secondary |
| 207N00000X | Dermatology | MD61130459 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Multicare Health System | 7719899897 | 1704 |
News Archive
The American Association of Homes and Services for the Aging applauds the Senate's passage of legislation to extend the temporary increase in federal Medicaid funding through June 30, 2011.
Labopharm Inc. today introduced INTELLITAB(TM), the brand name for its proprietary abuse and misuse-deterrent technology platform. The INTELLITAB(TM) platform, which can deliver one or more therapeutic drugs in combination over periods of up to 24 hours, has the potential to provide a patient with a controlled release medication while minimizing the risk of intentional abuse or accidental misuse.
In the most detailed study to date of epidemic spread, an international team of researchers has modeled measles dynamics based on over 40 years of data collected in England and Wales.
Having blood drawn by a courteous health care provider can really take the sting out of those procedures, suggests a study being presented at the ANESTHESIOLOGY® 2019 annual meeting.
For many migraine sufferers, bright lights are a surefire way to exacerbate their headaches. And for some night-shift workers, just a stroll through a brightly lit parking lot during the morning commute home can be enough to throw off their body's daily rhythms and make daytime sleep nearly impossible. But a new molecule that selectively blocks specialized light-sensitive receptors in the eyes could help both these groups of people, without affecting normal vision.
› Verified 6 days ago
| Entity Name | Multicare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
The American Association of Homes and Services for the Aging applauds the Senate's passage of legislation to extend the temporary increase in federal Medicaid funding through June 30, 2011.
Labopharm Inc. today introduced INTELLITAB(TM), the brand name for its proprietary abuse and misuse-deterrent technology platform. The INTELLITAB(TM) platform, which can deliver one or more therapeutic drugs in combination over periods of up to 24 hours, has the potential to provide a patient with a controlled release medication while minimizing the risk of intentional abuse or accidental misuse.
In the most detailed study to date of epidemic spread, an international team of researchers has modeled measles dynamics based on over 40 years of data collected in England and Wales.
Having blood drawn by a courteous health care provider can really take the sting out of those procedures, suggests a study being presented at the ANESTHESIOLOGY® 2019 annual meeting.
For many migraine sufferers, bright lights are a surefire way to exacerbate their headaches. And for some night-shift workers, just a stroll through a brightly lit parking lot during the morning commute home can be enough to throw off their body's daily rhythms and make daytime sleep nearly impossible. But a new molecule that selectively blocks specialized light-sensitive receptors in the eyes could help both these groups of people, without affecting normal vision.
› Verified 6 days ago
| Entity Name | Franciscan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093165334 PECOS PAC ID: 0547173866 Enrollment ID: O20031111000789 |
News Archive
The American Association of Homes and Services for the Aging applauds the Senate's passage of legislation to extend the temporary increase in federal Medicaid funding through June 30, 2011.
Labopharm Inc. today introduced INTELLITAB(TM), the brand name for its proprietary abuse and misuse-deterrent technology platform. The INTELLITAB(TM) platform, which can deliver one or more therapeutic drugs in combination over periods of up to 24 hours, has the potential to provide a patient with a controlled release medication while minimizing the risk of intentional abuse or accidental misuse.
In the most detailed study to date of epidemic spread, an international team of researchers has modeled measles dynamics based on over 40 years of data collected in England and Wales.
Having blood drawn by a courteous health care provider can really take the sting out of those procedures, suggests a study being presented at the ANESTHESIOLOGY® 2019 annual meeting.
For many migraine sufferers, bright lights are a surefire way to exacerbate their headaches. And for some night-shift workers, just a stroll through a brightly lit parking lot during the morning commute home can be enough to throw off their body's daily rhythms and make daytime sleep nearly impossible. But a new molecule that selectively blocks specialized light-sensitive receptors in the eyes could help both these groups of people, without affecting normal vision.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Christian Larrymore, MD 565 Eureka Way, Sequim, WA 98382-5074 Ph: (360) 582-0808 | Dr David Christian Larrymore, MD 565 Eureka Way, Sequim, WA 98382-5074 Ph: (360) 582-0808 |
News Archive
The American Association of Homes and Services for the Aging applauds the Senate's passage of legislation to extend the temporary increase in federal Medicaid funding through June 30, 2011.
Labopharm Inc. today introduced INTELLITAB(TM), the brand name for its proprietary abuse and misuse-deterrent technology platform. The INTELLITAB(TM) platform, which can deliver one or more therapeutic drugs in combination over periods of up to 24 hours, has the potential to provide a patient with a controlled release medication while minimizing the risk of intentional abuse or accidental misuse.
In the most detailed study to date of epidemic spread, an international team of researchers has modeled measles dynamics based on over 40 years of data collected in England and Wales.
Having blood drawn by a courteous health care provider can really take the sting out of those procedures, suggests a study being presented at the ANESTHESIOLOGY® 2019 annual meeting.
For many migraine sufferers, bright lights are a surefire way to exacerbate their headaches. And for some night-shift workers, just a stroll through a brightly lit parking lot during the morning commute home can be enough to throw off their body's daily rhythms and make daytime sleep nearly impossible. But a new molecule that selectively blocks specialized light-sensitive receptors in the eyes could help both these groups of people, without affecting normal vision.
› Verified 6 days ago
Dr. Claire L Haycox, MD, PHD Dermatology Medicare: Medicare Enrolled Practice Location: 565 Eureka Way, Sequim, WA 98382 Phone: 360-582-0808 | |
Agnieszka J. Niemeyer, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 558 N 5th Ave, Sequim, WA 98382 Phone: 360-681-6900 Fax: 360-681-6222 | |
Heidi M Hermes Shantz, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 565 Eureka Way, Sequim, WA 98382 Phone: 360-582-0808 Fax: 253-984-2049 |